One very powerful signal in favor of GNTA is the level of institutional ownership. If Ameritrade is correct, approximately 25% of GNTA is owned by institutional investors. That is a powerful vote of confidence that the science this company works on has great value. There are not that many small sub penny pharmaceutical stocks that get noticed by institutional investors. Whenever you find them, stick around--something good is cooking in the oven.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.